Total Funding
40
51
Total FundingSeed raised
Growth Score 40 in past quarter
-6 pts
Heat Score 51 in past quarter
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
105474
Innoblative is a medical device company whose mission is to develop innovative advanced energy medical devices.
Tyler Wanke: Chief Executive Officer & Co-Founder
Robert Rioux: CTO & COO
About the Company
Innoblative is developing Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. Sira’s unique design and saline microinfusion system allow it to have unparalleled contact with target tissue and to be powered with existing electrosurgical generators
already installed in the operating room. This device represents an exciting new option for intraoperative ablation of soft tissue which surgeons can easily adopt.
